Insider Trading April 3, 2026

Huron Consulting Director Executes $63,840 Stock Sale; Company Posts Mixed Signals

Director sale stems from pre-set plan as Huron beats EPS while guidance range and AI concerns pressure shares

By Ajmal Hussain HURN
Huron Consulting Director Executes $63,840 Stock Sale; Company Posts Mixed Signals
HURN

John McCartney, a director at Huron Consulting Group Inc., sold 500 shares on April 1, 2026, under a Rule 10b5-1 plan for $63,840. The transaction occurred as the stock traded at $130.35, down about 25% year-to-date. Huron reported fourth-quarter adjusted EPS above expectations and revenue growth, yet shares declined after management provided a wide guidance range for 2026 and cited potential impacts from artificial intelligence. Benchmark maintained a Buy rating and a $215 price target after modest model updates.

Key Points

  • Director John McCartney sold 500 shares on April 1, 2026, at $127.68 per share for $63,840 under a Rule 10b5-1 trading plan.
  • Huron reported adjusted Q4 EPS of $2.17 versus a $1.95 consensus and revenue before reimbursables of $432.3 million, up 11.3% but slightly below the $433.57 million estimate.
  • Benchmark maintained a Buy rating and $215 price target after modest model updates, while shares fell on a wide 2026 guidance range and AI-related concerns.

Director John McCartney of Huron Consulting Group Inc. (NASDAQ:HURN) executed a sale of 500 common shares on April 1, 2026, at $127.68 per share, yielding a total transaction value of $63,840. The trade was carried out under an automatic, pre-arranged Rule 10b5-1 trading plan that McCartney adopted on August 15, 2024.

At the time of the sale Huron shares were trading at $130.35, representing a roughly 25% decline year-to-date. InvestingPro analysis, referenced in company reporting, indicates the stock remains undervalued relative to its Fair Value.

Following the disposition of the 500 shares, McCartney retains direct ownership of 40,817 shares of Huron Consulting Group Inc.


Earnings and revenue results

Huron released fourth-quarter results that topped analyst expectations on the bottom line. The company reported adjusted earnings per share of $2.17 versus a consensus estimate of $1.95. Revenue before reimbursable expenses rose 11.3% to $432.3 million, driven by strong performance in the healthcare and commercial segments, though that revenue figure marginally missed the consensus estimate of $433.57 million.

Despite the earnings beat and revenue growth, the companys shares moved lower following the announcement. Market participants were reportedly unsettled by Hurons wide guidance range for 2026 and commentary about the potential effects of artificial intelligence on the business.


Analyst view and valuation notes

Benchmark reiterated its Buy rating on Huron and maintained a $215.00 price target. The firm updated its 2026 model and initiated a 2027 outlook, citing Hurons revenue growth algorithm and expectations for annual expansion in EBITDA margins. Benchmark noted only modest adjustments were necessary to their projections, signaling continued confidence in Hurons financial trajectory.

For investors seeking additional context on valuation and performance, a comprehensive Pro Research Report covering HURN and more than 1,400 other U.S. equities is available on InvestingPro.


Takeaway

The director sale was processed automatically under a plan established in 2024 and does not introduce any new stated intentions by management. Company fundamentals for the most recent quarter included an EPS beat and double-digit revenue growth, but market reaction to forward guidance and AI-related uncertainty led to downward pressure on the stock despite analyst reaffirmations.

Risks

  • Wide guidance range for 2026 injected uncertainty into near-term expectations, contributing to share-price volatility - impacts equity investors and the consulting sector.
  • Potential effects of artificial intelligence on Huron's business introduced concern among market participants, affecting sentiment in the professional services and technology-adjacent consulting markets.
  • Revenue slightly missing the consensus, despite growth, highlights execution and forecasting risks for Huron in a competitive consulting environment - relevant to healthcare and commercial consulting segments.

More from Insider Trading

Samsara CFO Disposes $640,673 in Class A Shares; Ownership Stakes Still Substantial Apr 3, 2026 Teradyne President Executes Stock Sales as Company Rolls Out New Test Platforms Apr 3, 2026 GlobalFoundries CBO Sells $81,072 in Shares as Company Weighs Legal and Shareholder Moves Apr 3, 2026 Forager Fund Sells 950,000 RPAY Shares in Two Trades Totaling $2.41 Million Apr 3, 2026 Ciena General Counsel Sells $808,240 in Stock as Shares Trade Near 52-Week High Apr 3, 2026